出版國家:Japan
出版周期:月刊
影響因子:2.041
研究領(lǐng)域:免疫學
5年影響因子:1.892
國外數(shù)據(jù)庫收錄:IM,2.041" />
醫(yī)學全在線
醫(yī)學全在線首頁-醫(yī)師-藥師-護士-衛(wèi)生資格-高級職稱-考試題庫-網(wǎng)校-考研-圖譜-下載-招聘  
分類
國家級省級浙江省各省雜志
科技核心北大核心CSCDCSCD擴展
工具
期刊知識寫作指導 論文投稿推薦期刊
期刊驗證論文檢測 錄用通知往期目錄
SCI
SCI指導影響因子
期刊點評基金動態(tài)
其它
經(jīng)濟教育計算機
建筑體育農(nóng)業(yè)
北京|天津|河北|山西|湖北|江蘇|安徽|山東|上海|浙江|江西|福建|湖南|寧夏|內(nèi)蒙古|河南
四川|重慶|貴州|云南|遼寧|吉林|廣東|廣西|海南|陜西|甘肅|新疆|青海|衛(wèi)生部直屬|黑龍江|兵團
您現(xiàn)在的位置: 醫(yī)學全在線 > 醫(yī)學論文 > SCI期刊 > 正文:JOURNAL OF ANTIBIOTICS if:2.041
    

JOURNAL OF ANTIBIOTICS


JOURNAL OF ANTIBIOTICS
影響因子: 2.041
I S S N: 0021-8820
出 版 社: Japan Antibiotics Research Assn
出 版 地: Tokyo
出版國家: Japan
刊  期: 月刊
創(chuàng)刊時間: 1953
語  種: 英文
審稿周期: 平均2月
中科院分區(qū): 4
投稿命中率: 約50%
國外數(shù)據(jù)庫收錄: IM
中國收錄文章數(shù): 89
5年影響因子: 1.892
研究領(lǐng)域: 免疫學
官方鏈接: http://www.nature.com/ja/index.html
投稿須知: http://www.nature.com/ja/index.html

期刊介紹:

well as the traditional research and development model of finding replacement drugs to tackle this problem, there are other important new strategies for addressing resistance which include research into bioactive microbial products. The Journal of Antibiotics forms an integral part of this battle against resistance by encouraging and publishing original research articles that report findings of wide biological significance in the multidisciplinary field of antimicrobials. We specifically encourage articles that represent important advances in the field of antimicrobial research, including recently discovered antibiotics, bioactive microbial products and novel strategies for combating antibiotic resistance. The Journal of Antibiotics provides a dynamic platform for communicating research on microbial products and antimicrobial approaches through also including insightful and up-to-date reviews, short communications and letters to the editor.
...
關(guān)于我們 - 聯(lián)系我們 -版權(quán)申明 -誠聘英才 - 網(wǎng)站地圖 - 網(wǎng)絡課程 - 幫助
醫(yī)學全在線 版權(quán)所有© CopyRight 2006-2046, MED126.COM, All Rights Reserved
浙ICP備12017320號
百度大聯(lián)盟認證綠色會員實名網(wǎng)站 360認證可信網(wǎng)站 中網(wǎng)驗證